Group's Second Paper on Treatments for COVID-19 Is Retracted

www.medscape.com
2 min read
fairly difficult
A group of researchers in Egypt have lost a second paper on possible treatments for COVID-19 after questions were raised about the legitimacy of their trial findings.
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

A group of researchers in Egypt have lost a second paper on possible treatments for Covid-19 after questions were raised about the legitimacy of their trial findings — and additional retractions might be coming soon.

As we reported in September, the group lost an article in Scientific Reports about a purported trial comparing favipiravir and hydroxychloroquine to treat the infection.

That move followed an expression of concern, issued in early August, for a paper in the Archives of Virology by Dabbous and his colleagues about favipiravir, titled "Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study."

The journal has now retracted the article:

The Editor-in-Chief has retracted this article. After publication, concerns were raised about the reporting of this clinical trial and the authors were asked to provide their raw data files. The raw data underlying Table 1 were examined. First, the reported…
Retraction Watch Staff
Read full article